147 related articles for article (PubMed ID: 4522066)
1. Side effects observed during intermittent rifampicin therapy.
Stradling P
Scand J Respir Dis Suppl; 1973; 84():129-31. PubMed ID: 4522066
[No Abstract] [Full Text] [Related]
2. Clinical aspects of side effects on intermittent rifampicin regimen.
Zierski M
Scand J Respir Dis Suppl; 1973; 84():166-73. PubMed ID: 4522072
[No Abstract] [Full Text] [Related]
3. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
Guerra Sanz FJ
Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
[No Abstract] [Full Text] [Related]
4. Intermittent rifampicin treatment of tuberculosis.
Riska N; Mattson K
Scand J Respir Dis Suppl; 1973; 84():140-4. PubMed ID: 4522069
[No Abstract] [Full Text] [Related]
5. The intermittent chemotherapy of tuberculosis with rifampicin regimens on ambulatory basis.
Anastasatu C; Bungeteanu G; Sibila S
Scand J Respir Dis Suppl; 1973; 84():136-9. PubMed ID: 4522068
[No Abstract] [Full Text] [Related]
6. Proceedings of the Workshop on Intermittent Drug Therapy and Immunological Implications in Antituberculous Treatment with Rifampicin. Oct. 2-3, 1972 Stockholm. Organized by The Department of Thoracic Medicine, Karolinska Sjukhuset.
Scand J Respir Dis Suppl; 1973; 84():1-193. PubMed ID: 4593267
[No Abstract] [Full Text] [Related]
7. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
Eule H; Werner E; Winsel K; Iwainsky H
Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
[No Abstract] [Full Text] [Related]
8. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
Nitti V
Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
[No Abstract] [Full Text] [Related]
9. Preliminary results of a controlled therapeutic trail administering INH-RMP once-weekly, after--or without--an initial period of continuous treatment.
Eule H; Kärnbach E; Kaluza P; Herrmann H
Scand J Respir Dis Suppl; 1973; 84():153-9. PubMed ID: 4593264
[No Abstract] [Full Text] [Related]
10. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions.
Girling DJ
Scand J Respir Dis Suppl; 1973; 84():119-24. PubMed ID: 4522064
[No Abstract] [Full Text] [Related]
11. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
Girling DJ
Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
[No Abstract] [Full Text] [Related]
12. [Proceedings: Rifampicin adverse effects in intermittent therapy].
Herrmann H; Eule H; Lau W; Kuhnert R; Fanter D; Kahlau U; Schönert E; Werner E
Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):146-58. PubMed ID: 4491712
[No Abstract] [Full Text] [Related]
13. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
[No Abstract] [Full Text] [Related]
14. Immunological and haematological investigations on patients with adverse reactions during treatment with RMP plus INH once-weekly.
Herrmann H; Eule H
Scand J Respir Dis Suppl; 1973; 84():87-93. PubMed ID: 4593270
[No Abstract] [Full Text] [Related]
15. Haematological changes during intermittent treatment with rifampicin.
Wislawska-Orlowska B; Pniewski T
Scand J Respir Dis Suppl; 1973; 84():94-7. PubMed ID: 4522080
[No Abstract] [Full Text] [Related]
16. Rifampicin-dependent antibodies in twice-weekly treated patients.
Algeorge G; Rudescu D; Alexandrescu D
Scand J Respir Dis Suppl; 1973; 84():98-101. PubMed ID: 4522081
[No Abstract] [Full Text] [Related]
17. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
[No Abstract] [Full Text] [Related]
18. Curative effect of a course of monotherapy with rifampicin, isoniazid or streptomycin subsequent to combination treatment in murine tuberculosis.
Kradolfer F; Schnell R
Arzneimittelforschung; 1973 Oct; 23(10):1462-4. PubMed ID: 4591314
[No Abstract] [Full Text] [Related]
19. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency of side-effects.
Eule H; Werner E; Winsel K; Iwainsky H
Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4470836
[No Abstract] [Full Text] [Related]
20. [Treatment of tuberculosis with streptomycin and isoniazide combined with either aminosalyl or rifampicin].
Engbaek HC; Larsen SO; Rasmussen KN; Vergmann B
Ugeskr Laeger; 1973 Aug; 135(34):1795-9. PubMed ID: 4592618
[No Abstract] [Full Text] [Related]
[Next] [New Search]
